Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
127154831	12715483	1	I		20160824	20160906	20160906	EXP		BE-CIPLA LTD.-2016BE17787	CIPLA		0.00				Y	0.00000		20160906		OT	BE	BE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	RECHAL	NDA NUM	DOSE AMT	DOSE UNIT
127154831	12715483	1	PS	Irinotecan	IRINOTECAN	1	Unknown	UNK			77219
127154831	12715483	2	SS	OXALIPLATIN.	OXALIPLATIN	1	Unknown	UNK			0
127154831	12715483	3	SS	Bevacizumab	BEVACIZUMAB	1	Unknown	UNK			0
127154831	12715483	4	SS	Panitumumab	PANITUMUMAB	1	Unknown	UNK			0
127154831	12715483	5	SS	Cetuximab	CETUXIMAB	1	Unknown	UNK			0
127154831	12715483	6	SS	Regorafenib	REGORAFENIB	1	Oral	160 MG/DAY, 3 WEEKS ON EACH 4WEEK CYCLE	Y	U	0	160	MG

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
127154831	12715483	1	Colorectal cancer metastatic
127154831	12715483	2	Colorectal cancer metastatic
127154831	12715483	3	Colorectal cancer metastatic
127154831	12715483	4	Colorectal cancer metastatic
127154831	12715483	5	Colorectal cancer metastatic
127154831	12715483	6	Colorectal cancer metastatic

Outcome of event

Event ID	CASEID	OUTC COD
127154831	12715483	DE
127154831	12715483	OT

Reactions reported

Event ID	CASEID	PT
127154831	12715483	Disease progression
127154831	12715483	Hepatitis toxic
127154831	12715483	Neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

no results found

no results found